Metro East Drug Treatment (EIN 382020044) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1973

Legal Domicile

Principal Officer

Leslie Carroll II

Tax Period

2022-01-01 to 2022-12-31

Metro East Drug Treatment, founded in 1973, is a community nonprofit that reported $1.1M in total revenue in fiscal year 2022. Revenue surged 21% from the prior year, signaling strong growth momentum.

Mission

To provide rehabilitation services including, but not limited to, methadone manintenance, ethadone detox and related therapy to persons addicted to or afflicted with drugs and associated drug abuse problems.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2022)

Revenue Breakdown

Contributions & Grants $1,142,255

Program Service Revenue $1,319

Investment Income $0

Other Revenue $0

TOTAL REVENUE $1,143,574

Expense Breakdown

Grants Paid $0

Salaries & Benefits $796,830

Fundraising Expenses $0

Program Expenses $722,464

Other Expenses $359,896

TOTAL EXPENSES $1,156,726

Year-over-Year Comparison

	2022	2021	Change
Revenue	$1,143,574	$942,152	+0.2%
Expenses	$1,156,726	$1,044,693	+0.1%
Net Income	$-13,152	$-102,541	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Larry Barnett Sr	Member	10.00	Director	$0	$0	$0
Adrienne Haralson	Member	10.00	Director	$0	$0	$0
Vanessa Stafford	Member	10.00	Director	$0	$0	$0
Charlene Thomas	Member	10.00	Director	$0	$0	$0
Antonette McIllwain	Chairperson	10.00	Officer Director	$0	$0	$0
Johnnie Robinson	Secretary	40.00	Officer Director	$0	$0	$0
Leslie Carroll II	Executive Director	40.00	Officer Key Emp	$0	$0	$0
Jeanette Dave	Key Employee	40.00	Key Emp	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2022	$1,143,574	$1,156,726	$439,272	$-13,152
2021	$942,152	$1,048,122	$589,387	$-105,970
2020	$1,297,969	$1,067,382	$566,489	$230,587
2019	$1,099,347	$1,152,803	$341,164	$-53,456
2018	$1,042,826	$1,027,999	$394,534	$14,827

Metro East Drug Treatment